Recruiting
A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.
NCT06823752
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dementia, +14 more
- Locations
-
- Woolcock Institute of Medical Research Macquarie Park, New South Wales, Australia